CINC
CinCor Pharma, Inc. Common Stock
CINC
CINC
Delisted
CINC was delisted on the 23rd of February, 2023.
102 hedge funds and large institutions have $461M invested in CinCor Pharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 19 closing their positions.
Holders
102
Holders Change
+16
Holders Change %
+18.6%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
35
Increased
34
Reduced
19
Closed
19
Calls
$2.68M
Puts
$8.47M
Net Calls
-$5.79M
Net Calls Change
-$2.72M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$23.4M |
| 2 |
GPP
2
Great Point Partners
Greenwich,
Connecticut
|
$12.5M |
| 3 |
3
BlackRock
New York
|
$21.9M |
| 4 |
SFM
4
Sphera Funds Management
Tel Aviv,
Israel
|
$6.51M |
| 5 |
SCM
5
Silverarc Capital Management
Boston,
Massachusetts
|
$4.86M |
